Effect of Pneumococcal Conjugate Vaccine on Pneumonia Incidence Rates among Children 2–59 Months of Age, Mongolia, 2015–2021

Starting in June 2016, the 13-valent pneumococcal conjugate vaccine (PCV13) was introduced into the routine immunization program of Mongolia by using a 2+1 dosing schedule, phased by district. We used prospective hospital surveillance to evaluate the vaccine’s effect on pneumonia incidence rates am...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Claire von Mollendorf, Munkhchuluun Ulziibayar, Cattram D. Nguyen, Purevsuren Batsaikhan, Bujinlkham Suuri, Dashtseren Luvsantseren, Dorj Narangerel, John de Campo, Margaret de Campo, Bilegtsaikhan Tsolmon, Sodbayar Demberelsuren, Eileen M. Dunne, Catherine Satzke, Tuya Mungun, E. Kim Mulholland
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	Centers for Disease Control and Prevention 2024-03-01
سلاسل:	Emerging Infectious Diseases
الموضوعات:	pneumonia pneumococcal conjugate vaccine PCV13 hospitalization children bacteria
الوصول للمادة أونلاين:	https://wwwnc.cdc.gov/eid/article/30/3/23-0864_article
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!